Why the study?
RVs are major respiratory pathogens, with RV-C species causing more severe illnesses and asthma exacerbations, making rapid and sensitive detection of neutralizing antibodies important for vaccine and antiviral drug development.
Population
64 human serum samples collected from a wide range of age groups
Comparison
Nt-ELISPOT vs traditional cytopathic effect-based neutralization assay (Nt-CPE)
Design
Preclinical assay development and validation study
Authors
Loading...
May aid RV-C research assays; leaves open clinical diagnostic or vaccine utility pending validation.
The developed Nt-ELISPOT assay provides a rapid, high-throughput method for detecting neutralizing antibodies against Rhinovirus C15, revealing a 48.4% seroprevalence in a healthy Chinese cohort.
Zhou et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: